GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in …
Over the last 12 months, insiders at GeneDx Holdings Corp. have bought $8.55M and sold $116.22M worth of GeneDx Holdings Corp. stock.
On average, over the past 5 years, insiders at GeneDx Holdings Corp. have bought $57.01M and sold $30.5M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Casdin Capital, LLC () — $34.19M.
The last purchase of 30,000 shares for transaction amount of $675,477 was made by Casdin Capital, LLC () on 2024‑06‑04.
2024-12-16 | Sale | Chief Executive Officer | 10,501 0.0371% | $76.75 | $805,995 | -2.73% | ||
2024-12-16 | Sale | CHIEF FINANCIAL OFFICER | 3,728 0.0132% | $76.75 | $286,139 | -2.73% | ||
2024-12-09 | Sale | Chief Executive Officer | 3,661 0.0139% | $76.37 | $279,598 | +3.53% | ||
2024-12-09 | Sale | CHIEF FINANCIAL OFFICER | 1,137 0.0043% | $76.37 | $86,836 | +3.53% | ||
2024-12-02 | Sale | CHIEF FINANCIAL OFFICER | 263 0.001% | $78.39 | $20,617 | -1.20% | ||
2024-11-22 | Sale | CHIEF FINANCIAL OFFICER | 9,981 0.0353% | $76.07 | $759,242 | -1.66% | ||
2024-11-21 | Sale | CHIEF FINANCIAL OFFICER | 12,019 0.0412% | $73.76 | $886,568 | +8.08% | ||
2024-11-20 | Sale | director | 15,490 0.0497% | $69.13 | $1.07M | +11.56% | ||
2024-11-19 | Sale | director | 31,510 0.1043% | $71.28 | $2.25M | +8.84% | ||
2024-11-18 | Sale | 10 percent owner | 126,782 0.4167% | $70.78 | $8.97M | +8.64% | ||
2024-11-18 | Sale | Chief Executive Officer | 22,307 0.0729% | $70.34 | $1.57M | +8.64% | ||
2024-11-15 | Sale | 10 percent owner | 20,359 0.066% | $69.78 | $1.42M | +12.85% | ||
2024-11-15 | Sale | Chief Executive Officer | 23,108 0.0756% | $70.48 | $1.63M | +12.85% | ||
2024-10-31 | Sale | 10 percent owner | 865,800 3.0153% | $75.00 | $64.94M | -7.03% | ||
2024-10-29 | Sale | Chief Executive Officer | 2,154 0.0067% | $66.60 | $143,456 | -8.45% | ||
2024-10-29 | Sale | CHIEF FINANCIAL OFFICER | 274 0.0008% | $66.60 | $18,248 | -8.45% | ||
2024-09-16 | Sale | Chief Executive Officer | 10,501 0.0183% | $37.59 | $394,733 | +88.41% | ||
2024-09-16 | Sale | CHIEF FINANCIAL OFFICER | 2,635 0.0046% | $37.59 | $99,050 | +88.41% | ||
2024-09-09 | Sale | Chief Executive Officer | 3,639 0.0056% | $33.33 | $121,288 | +102.88% | ||
2024-09-09 | Sale | CHIEF FINANCIAL OFFICER | 895 0.0014% | $33.33 | $29,830 | +102.88% |
Casdin Capital, LLC | 3093509 11.2608% | $77.40 | 9 | 0 | ||
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 10 percent owner | 2719692 9.9001% | $77.40 | 1 | 3 | <0.0001% |
OPKO HEALTH, INC. | 10 percent owner | 2646972 9.6354% | $77.40 | 1 | 19 | <0.0001% |
Stueland Katherine | Chief Executive Officer | 71146 0.259% | $77.40 | 1 | 21 | <0.0001% |
Ryan Jason | director | 0 0% | $77.40 | 2 | 5 | +1256.88% |